AGO2 and cancer: Previously, a number of studies have demonstrated deregulation of miRNA in gastric cancer [46-50] and the importance of the entire microRNA system has been documented in both gastric and colon cancer by the presence of cancer-specific mutations in the key RISC components AGO2 and TNRC6A [51].